Therapeutic Specialist- IBU (関西エリア） at Gilead Sciences

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Strong commitment to making the best product in advanced treatments that help patients
Experience in JAK inhibitors, biological agents, or rheumatoid arthritis (RA) field
No participation in PIP program (or not currently participating)
Possession of MR (Medical Representative) qualification
Nice to have
Experience in partner business (co-promotion)
Proactivity in voicing opinions/proposals and taking initiative
Ability to tackle challenging problems or new tasks with a challenging spirit and perseverance to achieve goals

Responsibilities

Achieve sales targets
Enhance medical professionals' understanding of product characteristics and positioning
Execute various KPIs (planned visits, communication with physicians, communication with partners)
Contribute to the business unit: share acquired knowledge, share knowledge/experience with team, engage in proposal activities
Conduct events independently or in collaboration with marketing department
Collect insights from medical professionals, market trends, and other information

Skills

JAK阻害剤

関節リウマチ

MR資格

営業

プロモーション

KPI管理

医療従事者対応

市場インサイト

チーム連携

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free